10:00 - 10:10 AM Welcome by Abi Barrow, Cambridge Innovation Partners for the ICCS Organizing Partners. Opening Remarks by Bernd Mühlenweg, SVP, Head of Global BD, Cell Therapy Evotec "From Breakthroughs to Business Models: The Cell Therapy Landscape in Transition"
10:10 - 11:00 AM Expert Panel: From Discovery to Delivery - A Call for Transformative Partnerships Moderated by Jutta Heix, Head of International Affairs, Oslo Cancer Cluster.
12 start-ups from European, US and Asian innovation hubs give 3,5 min pitches complemented by 1,5 min feedback per company. Plus: opportunity for more detailed feedback and discussions during the Networking Lunch.
Pan Cancer T (NL); Anocca (SWE); T-Knife (GER); InnDura (US); Strike Pharma (SWE); Chimeron Bio (US); AlterBio (US); iXgene (Japan); TILT Biotherapeutics (FIN); Monarch Therapeutics (US); ImmunoKey (UK) and Limula (Switzerland)
12:00 - 12:05 PM Closing by Harpreet Singh, CMO Precision for Medicine: "Charting the Future: CGT Regulation in Europe and the US" Wrap up by ICCS Organizing Partners 12:05 - 12:30 PM Mingling & Light lunch